News
Waiting Time Policies in the Health Sector: What Works?
27 October 2015
On 16th September Professor Luigi Siciliani led an OHE lunchtime seminar on waiting time policies in the health sector. The slides are now available.
Just Published: Testing the Feasibility of Obtaining EQ-5D-5L Values in the United Arab Emirates
23 October 2015
This study tests the feasibility of eliciting EQ-5D-5L values from a general public sample in the United Arab Emirates.
OHE at ISPOR Latin America: Policy Options for Formulary Development in Middle-income Countries
20 October 2015
This post summarises OHE’s activities at this year’s ISPOR Latin America conference in Santiago, September 2015. Topics include policy options for formulary development in middle-income countries,…
Government and Charity Funding of Cancer Research: Public Preferences and Choices
13 October 2015
How might a change in government spending on cancer research affect the public’s willingness to donate to cancer research charities?
Professor Nancy Devlin Appointed to PHIN’s Board of Directors
9 October 2015
OHE’s Nancy Devlin has been appointed as a Non-Executive Director with the Private Healthcare Information Network (PHIN).
Future Cases of Dementia among People Born in 2015 & the Dementia Drug Pipeline
6 October 2015
It is estimated that one in three people born in 2015 in the UK may develop dementia, and clinical development success rates for dementia drugs are…
LSE-ICL Medical Innovation Forum on 14th October 2015: Assessing Value and Sustainable Financing of Innovative Therapies.
29 September 2015
OHE’s Adrian Towse to speak on Options for the Sustainable Financing of Innovative Therapies.
New Publication: Risk-Sharing Agreements Between Pharmaceutical Manufacturers and Payers
25 September 2015
Recently published is a study by a research team including OHE’s Adrian Towse which examines prospects for risk-sharing agreements between pharmaceutical manufacturers and payers in the…
OHE Lunchtime Seminar on 6 October 2015 PharmaDiplomacy: A Proposal for a Collaborative, Mutually Acceptable Approach to Drug Pricing
22 September 2015
On Tuesday 6th October, James Anderson (GSK), Ri De Ridder (RIZIV-INAMI), and Sophia Tickell (Meteosan) will take part in an OHE seminar to discuss the Checklist…